(UroToday.com) The 2024 American Society of Clinical Oncology (ASCO) annual meeting featured a session on prostate cancer, and a presentation by Dr. Michael Morris discussing a phase 1 study of ...
Suppliers are investing in production to support deals with AstraZeneca, Bayer and other drugmakers that are advancing radioisotope-based cancer therapies. The emergence of actinium-225 as the next ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results